Tenofovir use in a patient with a severe renal impairment

HIV Medicine

Volumn 5, Issue 6, 2004, Pages 450-451

  Di Biagio, Antonio ^a   Bassetti, M ^a   Briozzo, A ^a   Ferrazin, A ^a   Rosso, R ^a   Gatti, G ^a   Cruciani, M ^b   Bassetti, D ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Center of Preventive Medicine   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; CD4 ANTIGEN; CREATININE; DIDANOSINE; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR; ZIDOVUDINE;

ADULT; ANEMIA; ARTICLE; BLOOD TOXICITY; CASE REPORT; COMBINATION CHEMOTHERAPY; CREATININE CLEARANCE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TOLERABILITY; DRUG USE; FEMALE; GENOTYPE; HEMODIALYSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERAMYLASEMIA; HYPERGLYCEMIA; KIDNEY DYSFUNCTION; LEUKOPENIA; LIVER TOXICITY; LYMPHOCYTE COUNT; PATIENT COMPLIANCE; PRIORITY JOURNAL; VIRUS LOAD; VIRUS RESISTANCE;

ADENINE; ADULT; DIABETIC NEPHROPATHIES; DIDEOXYNUCLEOSIDES; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; LAMIVUDINE; PHOSPHONIC ACIDS; REVERSE TRANSCRIPTASE INHIBITORS; TREATMENT OUTCOME;

EID: 9244255249     PISSN: 14642662     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2004.00241.x     Document Type: Article

References (10)

1. Gallant JE, Deresinski S. Tenofovir disoproxil fumarate. Clin Infect Dis 2003; 31: 944-950.
2. Schaaf B, Aries SP, Kramme E, Steinhoff J, Dalhoff K. Acute renal failure associated with tenofovir treatment in a patient with acquired immunodeficiency syndrome. Clin Infect Dis 2003; 37: e41-e43.
3. Karras A, Lafaurie M, Furco A et al. Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus. Clin Infect Dis 2003; 36: 1070-1073.
4. Creput C, Gonzalez-Canali G, Hill G et al. Renal lesions in HIV-1-positive patient treated with tenofovir. AIDS 2003; 17: 935-937.
5. Verhelst D, Monge M, Meynard JL et al. Fanconi syndrome and renal failure induced by tenofovir: a first case report. Am J Kidney Dis 2002; 40: 1331-1033.
6. Farthing C, Khanlou H, Yeh V. Early virologic failure in a pilot study evaluating the efficacy of abacavir, lamivudine and tenofovir in the treatment naive HIV-infected patients. 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment. Paris, France, July 2003 [Abstract 43].
7. Gallant JE, Rodriguez AE, Weinberg W et al. Early non-response to tenofovir DF + abacavir and lamivudine in a randomized trial compared to efavirenz + abacavir and lamivudine: ESS30009 unplanned interim analysis. 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, IL, September 2003 [Abstract H-1722a].
8. Kearney BP, Liaw S, Yale K et al. Pharmacokinetics following single dose administration of tenofovir DF in patients with renal impairment. 6th International Congress on Drug Therapy. Glasgow, UK, November 2002 [Abstract P4].
9. GlaxoSmithKline. Epivir Prescribing Information. http://us.gsk.com/products/assets/us_epivir.pdf Last accessed 7 January 2004.
10. Gilead. Tenofovir Prescribing Information. https://www.viread.com/pi.pdf Last accessed 7 January 2004.